VIM and hepatocellular carcinoma: Mechanistically, LINC01488 positively affects miR-124-3p and miR-138-5p biogenesis to reduce vimentin expression and negatively regulates cyclin E via ubiquitination, leading to inhibition of metastasis and tumorigenesis in HCC.